IC

Ikarian Capital Portfolio holdings

AUM $773M
1-Year Est. Return 443.74%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+443.74%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$200M
AUM Growth
-$40.9M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
142
New
Increased
Reduced
Closed

Top Buys

1
+$12.2M
2
+$10.6M
3
+$7.73M
4
SAGE
Sage Therapeutics
SAGE
+$6.1M
5
CERE
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
+$5.3M

Top Sells

1
+$12.7M
2
+$11.3M
3
+$11.1M
4
UTHR icon
United Therapeutics
UTHR
+$9.43M
5
CLDX icon
Celldex Therapeutics
CLDX
+$6.76M

Sector Composition

1 Healthcare 98.33%
2 Consumer Staples 0%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$430K 0.21%
361,518
-60,821
52
$397K 0.2%
7,918
-3,099
53
$292K 0.15%
20,450
-11,174
54
$283K 0.14%
219,501
-458,358
55
$193K 0.1%
315,131
+15,131
56
$171K 0.09%
+4,519
57
$146K 0.07%
20,511
-3,758
58
$134K 0.07%
435,516
-66,320
59
$109K 0.05%
168,623
-775,808
60
$102K 0.05%
4,064
-16,741
61
$76K 0.04%
+176,980
62
$66K 0.03%
13,239
-15,512
63
$48K 0.02%
13,236
-2,343
64
$2K ﹤0.01%
+302
65
– –
-132,014
66
– –
-8,951
67
– –
0
68
– –
-375,000
69
– –
0
70
– –
-246,554
71
– –
-41,900
72
– –
0
73
– –
0
74
– –
0
75
– –
0
1 2
3
4 5